$AMN
AMN HEALTHCARE SERVICES INC Stock $amn

$amn Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-K Financial Statement

#000114275021000012 Filed on February 26, 2021

Income Statement

Concept	2020 Q4	2020 Q3	2020 Q2
Revenue	$631.3M	$551.6M	$608.4M
YoY Change	7.56%	-2.81%	13.67%
Cost Of Revenue	$423.7M	$367.0M	$410.8M
YoY Change	8.7%	-2.8%	15.51%
Gross Profit	$207.5M	$184.6M	$197.5M
YoY Change	5.28%	-2.84%	10.02%
Gross Profit Margin	32.88%	33.47%	32.47%
Selling, General & Admin	$124.2M	$111.2M	$137.1M
YoY Change	-6.76%	-16.49%	12.66%
% of Gross Profit	59.84%	60.25%	69.39%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$24.10M	$27.40M	$22.50M
YoY Change	41.76%	60.37%	76.91%
% of Gross Profit	11.61%	14.84%	11.39%
Operating Expenses	$147.9M	$138.2M	$159.1M
YoY Change	-1.47%	-8.06%	18.42%
Operating Profit	$59.64M	$46.46M	$38.40M
YoY Change	26.8%	16.92%	-14.96%
Interest Expense	-$22.70M	$12.56M	$11.44M
YoY Change	155.06%	60.46%	88.67%
% of Operating Profit	-38.06%	27.04%	29.8%
Other Income/Expense, Net	-$16.10M		-$20.98M
YoY Change	-47.23%		-30.64%
Pretax Income	$6.000M	$33.90M	$26.96M
YoY Change	-84.25%	6.23%	-31.04%
Income Tax	-$3.300M	$7.831M	$4.633M
% Of Pretax Income	-55.0%	23.1%	17.19%
Net Earnings	$9.308M	$26.07M	$22.33M
YoY Change	-66.13%	10.85%	-22.67%
Net Earnings / Revenue	1.47%	4.73%	3.67%
Basic Earnings Per Share	$0.20	$0.55	$0.47
Diluted Earnings Per Share	$0.19	$0.55	$0.47
COMMON SHARES
Basic Shares Outstanding	47.03M shares	47.48M shares	47.38M shares
Diluted Shares Outstanding		47.68M shares	47.56M shares

Balance Sheet

Concept	2020 Q4	2020 Q3	2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$29.20M	$58.40M	$43.10M
YoY Change	-64.82%	43.49%	106.22%
Cash & Equivalents	$29.21M	$58.42M	$43.07M
Short-Term Investments	$868.0M		$1.110B
Other Short-Term Assets	$40.81M	$30.59M	$34.98M
YoY Change	0.9%	-18.13%	-1.56%
Inventory	$3.382B		$3.560B
Prepaid Expenses	$13.63M	$15.65M	$15.55M
Receivables	$376.1M	$352.7M	$366.6M
Other Receivables	$6.600M	$0.00	$0.00
Total Short-Term Assets	$533.7M	$513.7M	$518.6M
YoY Change	-4.78%	1.34%	5.87%
LONG-TERM ASSETS
Property, Plant & Equipment	$116.2M	$112.8M	$114.0M
YoY Change	10.82%	12.53%	17.2%
Goodwill	$864.5M	$869.9M	$870.1M
YoY Change	45.16%	48.3%	47.86%
Intangibles	$564.9M	$580.7M	$599.7M
YoY Change	41.77%	45.01%	46.48%
Long-Term Investments	$1.944B		$1.876B
YoY Change	-5.14%		-4.89%
Other Assets	$135.1M	$125.8M	$120.9M
YoY Change	12.36%	8.96%	10.01%
Total Long-Term Assets	$1.820B	$1.831B	$1.846B
YoY Change	32.72%	35.23%	35.13%
TOTAL ASSETS
Total Short-Term Assets	$533.7M	$513.7M	$518.6M
Total Long-Term Assets	$1.820B	$1.831B	$1.846B
Total Assets	$2.354B	$2.345B	$2.365B
YoY Change	21.84%	26.0%	27.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$167.9M	$152.9M	$144.8M
YoY Change	7.52%	9.63%	16.16%
Accrued Expenses	$37.85M	$44.24M	$33.05M
YoY Change	4.14%	25.95%	-5.96%
Deferred Revenue	$11.00M	$11.90M	$11.76M
YoY Change	-6.65%	5.99%	6.39%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$4.688M	$9.400M	$7.800M
YoY Change		147.37%	105.26%
Total Short-Term Liabilities	$423.0M	$386.2M	$384.5M
YoY Change	11.86%	12.29%	21.37%
LONG-TERM LIABILITIES
Long-Term Debt	$858.0M	$894.5M	$956.1M
YoY Change	39.01%	46.18%	44.3%
Other Long-Term Liabilities	$107.9M	$95.74M	$73.62M
YoY Change	74.57%	60.48%	23.54%
Total Long-Term Liabilities	$107.9M	$95.74M	$73.62M
YoY Change	74.57%	60.48%	23.54%
TOTAL LIABILITIES
Total Short-Term Liabilities	$423.0M	$386.2M	$384.5M
Total Long-Term Liabilities	$107.9M	$95.74M	$73.62M
Total Liabilities	$1.534B	$1.538B	$1.587B
YoY Change	28.36%	33.03%	35.02%
SHAREHOLDERS EQUITY
Retained Earnings	$469.6M	$460.3M	$434.2M
YoY Change	17.38%	23.54%	24.39%
Common Stock	$496.0K	$495.0K	$495.0K
YoY Change	0.61%	0.41%	0.61%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$119.1M	$119.1M	$119.1M
YoY Change	0.0%	0.0%	0.0%
Treasury Stock Shares	2.561M shares	2.561M shares	2.561M shares
Shareholders Equity	$819.7M	$807.1M	$777.4M
YoY Change
Total Liabilities & Shareholders Equity	$2.354B	$2.345B	$2.365B
YoY Change	21.84%	26.0%	27.41%

Cashflow Statement

Concept	2020 Q4	2020 Q3	2020 Q2
OPERATING ACTIVITIES
Net Income	$9.308M	$26.07M	$22.33M
YoY Change	-66.13%	10.85%	-22.67%
Depreciation, Depletion And Amortization	$24.10M	$27.40M	$22.50M
YoY Change	41.76%	60.37%	76.91%
Cash From Operating Activities	$39.80M	$88.70M	$76.90M
YoY Change	-49.43%	9.64%	164.26%
INVESTING ACTIVITIES
Capital Expenditures	-$10.30M	-$7.700M	-$6.100M
YoY Change	-2.83%	-16.3%	-33.7%
Acquisitions
YoY Change
Other Investing Activities	$600.0K	-$7.600M	-$14.90M
YoY Change	-102.17%	105.41%	-92.37%
Cash From Investing Activities	-$9.700M	-$15.20M	-$21.20M
YoY Change	-74.61%	17.83%	-89.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-55.10M	-62.40M	-127.1M
YoY Change	-27650.0%	17.96%	-167.79%
NET CHANGE
Cash From Operating Activities	39.80M	88.70M	76.90M
Cash From Investing Activities	-9.700M	-15.20M	-21.20M
Cash From Financing Activities	-55.10M	-62.40M	-127.1M
Net Change In Cash	-25.00M	11.10M	-71.40M
YoY Change	-161.43%	-26.49%	-690.08%
FREE CASH FLOW
Cash From Operating Activities	$39.80M	$88.70M	$76.90M
Capital Expenditures	-$10.30M	-$7.700M	-$6.100M
Free Cash Flow	$50.10M	$96.40M	$83.00M
YoY Change	-43.9%	6.99%	116.71%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020	dei	Entity Central Index Key EntityCentralIndexKey	0001142750
CY2020	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2020	dei	Amendment Flag AmendmentFlag	false
CY2017	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	us-gaap:AccountingStandardsUpdate201409Member
CY2019	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	us-gaap:AccountingStandardsUpdate201613Member
CY2019	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	us-gaap:AccountingStandardsUpdate201613Member
CY2020	dei	Document Period End Date DocumentPeriodEndDate	2020-12-31
CY2020	dei	Document Type DocumentType	10-K
CY2020	dei	Document Annual Report DocumentAnnualReport	true
CY2020	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020	dei	Document Transition Report DocumentTransitionReport	false
CY2020	dei	Entity File Number EntityFileNumber	001-16753
CY2020	dei	Entity Registrant Name EntityRegistrantName	AMN HEALTHCARE SERVICES, INC.
CY2020	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2020	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	06-1500476
CY2020	dei	Entity Address Address Line1 EntityAddressAddressLine1	8840 Cypress Waters Boulevard
CY2020	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 300
CY2020	dei	Entity Address City Or Town EntityAddressCityOrTown	Dallas
CY2020	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2020	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75019
CY2020	dei	City Area Code CityAreaCode	866
CY2020	dei	Local Phone Number LocalPhoneNumber	871-8519
CY2020	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value
CY2020	dei	Trading Symbol TradingSymbol	AMN
CY2020	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2020	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2020	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2020	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2020	dei	Entity Small Business EntitySmallBusiness	false
CY2020	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2020	dei	Entity Shell Company EntityShellCompany	false
CY2020Q2	dei	Entity Public Float EntityPublicFloat	2111094202	USD
CY2021Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	47180479	shares
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	29213000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	82985000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	7043000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	3332000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	376099000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	352685000	USD
CY2020Q4	amn	Accountsreceivablesubcontractor Accountsreceivablesubcontractor	73985000	USD
CY2019Q4	amn	Accountsreceivablesubcontractor Accountsreceivablesubcontractor	72714000	USD
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	13629000	USD
CY2019Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	11669000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	40809000	USD
CY2019Q4	us-gaap	Other Assets Current OtherAssetsCurrent	40446000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	533735000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	560499000	USD
CY2020Q4	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	61347000	USD
CY2019Q4	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	62170000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	161752000	USD
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	132900000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	116174000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	77735000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	104832000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	89866000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	135120000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	120254000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	864485000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	595551000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	215234000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	151417000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	564911000	USD
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	398474000	USD
CY2020Q4	us-gaap	Assets Assets	2353507000	USD
CY2019Q4	us-gaap	Assets Assets	1931646000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	167881000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	156140000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	213414000	USD
CY2019Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	170932000	USD
CY2020Q4	us-gaap	Notes Payable Current NotesPayableCurrent	4688000	USD
CY2019Q4	us-gaap	Notes Payable Current NotesPayableCurrent	0	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	15032000	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	13943000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	11004000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	11788000	USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	10938000	USD
CY2019Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	25302000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	422957000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	378105000	USD
CY2020Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	857961000	USD
CY2019Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	617159000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	67205000	USD
CY2019Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	46618000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	77800000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	91209000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	107907000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	61813000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	1533830000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	1194904000	USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49614000	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	47053000	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49283000	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	46722000	shares
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	496000	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	493000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	468726000	USD
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	455193000	USD
CY2020Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	2561000	shares
CY2019Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	2561000	shares
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	119143000	USD
CY2019Q4	us-gaap	Treasury Stock Value TreasuryStockValue	119143000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	469558000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	400047000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	40000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	152000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	819677000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	736742000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2353507000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1931646000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2393714000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2222107000	USD
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2136074000	USD
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1601936000	USD
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1478642000	USD
CY2018	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1439691000	USD
CY2020	us-gaap	Gross Profit GrossProfit	791778000	USD
CY2019	us-gaap	Gross Profit GrossProfit	743465000	USD
CY2018	us-gaap	Gross Profit GrossProfit	696383000	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	549747000	USD
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	508030000	USD
CY2018	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	452318000	USD
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	92766000	USD
CY2019	us-gaap	Depreciation And Amortization DepreciationAndAmortization	58520000	USD
CY2018	us-gaap	Depreciation And Amortization DepreciationAndAmortization	41237000	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	642513000	USD
CY2019	us-gaap	Operating Expenses OperatingExpenses	566550000	USD
CY2018	us-gaap	Operating Expenses OperatingExpenses	493555000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	149265000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	176915000	USD
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	202828000	USD
CY2020	us-gaap	Interest Expense InterestExpense	57742000	USD
CY2019	us-gaap	Interest Expense InterestExpense	28427000	USD
CY2018	us-gaap	Interest Expense InterestExpense	16143000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	91523000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	148488000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	186685000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	20858000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	34500000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	44944000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	70665000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	113988000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	141741000	USD
CY2020	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-112000	USD
CY2019	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	1000	USD
CY2018	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	263000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-112000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	263000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	70553000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	113989000	USD
CY2018	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	142004000	USD
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.49
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.44
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.99
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.48
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.40
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.91
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	47424000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	46704000	shares
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	47371000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	47690000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	47593000	shares
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48668000	shares
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	562527000	USD
CY2018	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	67013000	USD
CY2018	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-11432000	USD
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10815000	USD
CY2018	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	142004000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	638990000	USD
CY2019	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	18705000	USD
CY2019	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-13773000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	16241000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	113989000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	736742000	USD
CY2020	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-6929000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	20465000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	70553000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	819677000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	70665000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	94187000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	58520000	USD
CY2018	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	41237000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	113988000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	141741000	USD
CY2020	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-4349000	USD
CY2019	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1984000	USD
CY2018	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	4841000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-4956000	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-594000	USD
CY2018	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-574000	USD
CY2020	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	4900000	USD
CY2019	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	7178000	USD
CY2018	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-2400000	USD
CY2020	amn	Accounts Receivable Credit Loss Expense Reversal And Sales Credits AccountsReceivableCreditLossExpenseReversalAndSalesCredits	6535000	USD
CY2019	amn	Accounts Receivable Credit Loss Expense Reversal And Sales Credits AccountsReceivableCreditLossExpenseReversalAndSalesCredits	6275000	USD
CY2018	amn	Accounts Receivable Credit Loss Expense Reversal And Sales Credits AccountsReceivableCreditLossExpenseReversalAndSalesCredits	9006000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-21628000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	913000	USD
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-667000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	20465000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	16241000	USD
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	10815000	USD
CY2020	amn	Gain Loss On Deferred Compensation GainLossOnDeferredCompensation	-1646000	USD
CY2019	amn	Gain Loss On Deferred Compensation GainLossOnDeferredCompensation	0	USD
CY2018	amn	Gain Loss On Deferred Compensation GainLossOnDeferredCompensation	0	USD
CY2020	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-4322000	USD
CY2019	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-484000	USD
CY2018	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-117000	USD
CY2020	us-gaap	Investment Income Amortization Of Discount InvestmentIncomeAmortizationOfDiscount	109000	USD
CY2019	us-gaap	Investment Income Amortization Of Discount InvestmentIncomeAmortizationOfDiscount	298000	USD
CY2018	us-gaap	Investment Income Amortization Of Discount InvestmentIncomeAmortizationOfDiscount	202000	USD
CY2020	amn	Lessee Operating Lease Noncash Expense Benefit LesseeOperatingLeaseNoncashExpenseBenefit	-589000	USD
CY2019	amn	Lessee Operating Lease Noncash Expense Benefit LesseeOperatingLeaseNoncashExpenseBenefit	5000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	7338000	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-28278000	USD
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1453000	USD
CY2020	amn	Increase Decreasein Accounts Receivablessubcontractor IncreaseDecreaseinAccountsReceivablessubcontractor	1271000	USD
CY2019	amn	Increase Decreasein Accounts Receivablessubcontractor IncreaseDecreaseinAccountsReceivablessubcontractor	22571000	USD
CY2018	amn	Increase Decreasein Accounts Receivablessubcontractor IncreaseDecreaseinAccountsReceivablessubcontractor	9131000	USD
CY2020	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	412000	USD
CY2019	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	4464000	USD
CY2018	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-15099000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	1342000	USD
CY2019	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-774000	USD
CY2018	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-4465000	USD
CY2020	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-2322000	USD
CY2019	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-2847000	USD
CY2018	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	1259000	USD
CY2020	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-3220000	USD
CY2019	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	12751000	USD
CY2018	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-5239000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	5562000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1925000	USD
CY2018	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	17154000	USD
CY2020	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	25856000	USD
CY2019	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	32758000	USD
CY2018	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	10252000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	41640000	USD
CY2019	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-6090000	USD
CY2018	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-8980000	USD
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1119000	USD
CY2019	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1806000	USD
CY2018	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	319000	USD
CY2020	us-gaap	Increase Decrease In Restricted Cash And Investments For Operating Activities IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities	-9000	USD
CY2019	us-gaap	Increase Decrease In Restricted Cash And Investments For Operating Activities IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities	-78000	USD
CY2018	us-gaap	Increase Decrease In Restricted Cash And Investments For Operating Activities IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities	92000	USD
CY2020	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	48311000	USD
CY2019	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	26309000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	256826000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	224862000	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	226993000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	37702000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	35218000	USD
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	35206000	USD
CY2018	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	33824000	USD
CY2020	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	32800000	USD
CY2019	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	32135000	USD
CY2018	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	25000000	USD
CY2020	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	USD
CY2019	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	USD
CY2018	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	6100000	USD
CY2020	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	527000	USD
CY2019	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0	USD
CY2018	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0	USD
CY2020	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	490000	USD
CY2019	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	779000	USD
CY2018	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	750000	USD
CY2020	amn	Payments To Fund Deferred Compensation Plan PaymentsToFundDeferredCompensationPlan	7171000	USD
CY2019	amn	Payments To Fund Deferred Compensation Plan PaymentsToFundDeferredCompensationPlan	12507000	USD
CY2018	amn	Payments To Fund Deferred Compensation Plan PaymentsToFundDeferredCompensationPlan	9917000	USD
CY2020	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	476491000	USD
CY2019	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	247906000	USD
CY2018	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	217360000	USD
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1400000	USD
CY2019	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1240000	USD
CY2018	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1180000	USD
CY2020	us-gaap	Proceeds From Previous Acquisition ProceedsFromPreviousAcquisition	66000	USD
CY2019	us-gaap	Proceeds From Previous Acquisition ProceedsFromPreviousAcquisition	0	USD
CY2018	us-gaap	Proceeds From Previous Acquisition ProceedsFromPreviousAcquisition	0	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-538172000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-291824000	USD
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-279337000	USD
CY2020	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	228125000	USD
CY2019	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	150000000	USD
CY2018	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	0	USD
CY2020	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	250000000	USD
CY2019	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	150000000	USD
CY2018	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	0	USD
CY2020	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	245000000	USD
CY2019	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	221000000	USD
CY2018	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	75000000	USD
CY2020	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	245000000	USD
CY2019	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	101000000	USD
CY2018	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	195000000	USD
CY2020	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	552000000	USD
CY2019	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	300000000	USD
CY2018	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	0	USD
CY2020	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	333330000	USD
CY2019	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	0	USD
CY2018	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	0	USD
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2019	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	18705000	USD
CY2018	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	67013000	USD
CY2020	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	11508000	USD
CY2019	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	5223000	USD
CY2018	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	2331000	USD
CY2020	amn	Payments For Previous Acquisition Earn Out Payment PaymentsForPreviousAcquisitionEarnOutPayment	10622000	USD
CY2019	amn	Payments For Previous Acquisition Earn Out Payment PaymentsForPreviousAcquisitionEarnOutPayment	5700000	USD
CY2018	amn	Payments For Previous Acquisition Earn Out Payment PaymentsForPreviousAcquisitionEarnOutPayment	1713000	USD
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	6929000	USD
CY2019	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	13773000	USD
CY2018	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	11432000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	211486000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	136599000	USD
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	37511000	USD
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-112000	USD
CY2019	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1000	USD
CY2018	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	263000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-69972000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	69638000	USD
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-14570000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	153962000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	84324000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	98894000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	83990000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	153962000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	84324000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	20052000	USD
CY2018	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	460000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	22652000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	23730000	USD
CY2018	us-gaap	Interest Paid Net InterestPaidNet	21283000	USD
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	17817000	USD
CY2020	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	389000	USD
CY2019	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	536000	USD
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	46258000	USD
CY2019	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	37747000	USD
CY2018	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	30593000	USD
CY2020	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	35733000	USD
CY2019	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	29660000	USD
CY2018	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	24026000	USD
CY2020	amn	Supplemental Disclosures Of Non Cash Investing And Financing Activities Goodwill SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesGoodwill	268971000	USD
CY2019	amn	Supplemental Disclosures Of Non Cash Investing And Financing Activities Goodwill SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesGoodwill	157036000	USD
CY2018	amn	Supplemental Disclosures Of Non Cash Investing And Financing Activities Goodwill SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesGoodwill	97910000	USD
CY2020	amn	Supplemental Disclosures Of Non Cash Investing And Financing Activities Intangible Assets SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesIntangibleAssets	228000000	USD
CY2019	amn	Supplemental Disclosures Of Non Cash Investing And Financing Activities Intangible Assets SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesIntangibleAssets	107580000	USD
CY2018	amn	Supplemental Disclosures Of Non Cash Investing And Financing Activities Intangible Assets SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesIntangibleAssets	122110000	USD
CY2020	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	56213000	USD
CY2019	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	31148000	USD
CY2018	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	16586000	USD
CY2020	amn	Noncash Or Part Noncash Acquisition Earn Out Liability NoncashOrPartNoncashAcquisitionEarnOutLiability	0	USD
CY2019	amn	Noncash Or Part Noncash Acquisition Earn Out Liability NoncashOrPartNoncashAcquisitionEarnOutLiability	15222000	USD
CY2018	amn	Noncash Or Part Noncash Acquisition Earn Out Liability NoncashOrPartNoncashAcquisitionEarnOutLiability	10100000	USD
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	476491000	USD
CY2019	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	247906000	USD
CY2018	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	217360000	USD
CY2020	amn	Purchaseoffixedassetsrecordedinaccountspayableandaccruedexpenses Purchaseoffixedassetsrecordedinaccountspayableandaccruedexpenses	3103000	USD
CY2019	amn	Purchaseoffixedassetsrecordedinaccountspayableandaccruedexpenses Purchaseoffixedassetsrecordedinaccountspayableandaccruedexpenses	2301000	USD
CY2018	amn	Purchaseoffixedassetsrecordedinaccountspayableandaccruedexpenses Purchaseoffixedassetsrecordedinaccountspayableandaccruedexpenses	1706000	USD
CY2020	us-gaap	Use Of Estimates UseOfEstimates	Use of Estimates<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. On an ongoing basis, the Company evaluates its estimates, including those related to goodwill and indefinite-lived intangible assets, professional liability reserve, contingent liabilities such as legal accruals, and income taxes. The Company bases these estimates on the information that is currently available and on various other assumptions that it believes are reasonable under the circumstances. Actual results could differ from those estimates under different assumptions or conditions.</span></div>The estimates used for, but not limited to, determining the collectability of accounts receivable, fair value of long-lived assets, and goodwill could be impacted by the COVID-19 pandemic. While the full impact of COVID-19, including the duration and severity of the pandemic, remains unknown, the Company has made appropriate estimates based on the facts and circumstances available as of the reporting date. Specifically, the Company continues to monitor the impacts of the pandemic on its customers’ liquidity and capital resources and, therefore, the Company’s ability to collect, or the timeliness of collection of accounts receivable. The impact of COVID-19 did not have a material effect on the Company’s estimates as of December 31, 2020. These estimates may change as new events occur and additional information is obtained.
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	29213000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	82985000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	18626000	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	18393000	USD
CY2020Q4	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	61347000	USD
CY2019Q4	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	62170000	USD
CY2020Q4	amn	Total Cash Cash Equivalents And Restricted Cash Cash Equivalentsand Investments TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments	109186000	USD
CY2019Q4	amn	Total Cash Cash Equivalents And Restricted Cash Cash Equivalentsand Investments TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments	163548000	USD
CY2020Q4	us-gaap	Restricted Investments RestrictedInvestments	25196000	USD
CY2019Q4	us-gaap	Restricted Investments RestrictedInvestments	9586000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	83990000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	153962000	USD
CY2020	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	11729000	USD
CY2019	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	9972000	USD
CY2020	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	11208000	USD
CY2019	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	11369000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	7043000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	3332000	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	4428000	USD
CY2020	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	2051000	USD
CY2020	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	Concentration of Credit Risk The majority of the Company’s business activity is with hospitals located throughout the United States. Credit is extended based on the evaluation of each entity’s financial condition. The Company’s cash and cash equivalents and restricted cash, cash equivalents and investments accounts are financial instruments that are exposed to concentration of credit risk. The Company maintains most of its cash, cash equivalents and investment balances with high-credit quality and federally insured institutions. However, restricted cash equivalents and investment balances may be invested in a non-federally insured money market account and commercial paper.
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	61347000	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	62170000	USD
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	41000	shares
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	43000	shares
CY2018	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	23000	shares
CY2020	us-gaap	Net Income Loss NetIncomeLoss	70665000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	113988000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	141741000	USD
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.49
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.44
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.99
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.48
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.40
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.91
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	47424000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	46704000	shares
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	47371000	shares
CY2020	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	266000	shares
CY2019	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	889000	shares
CY2018	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1297000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	47690000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	47593000	shares
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48668000	shares
CY2019	us-gaap	Interest Expense InterestExpense	28427000	USD
CY2018	us-gaap	Depreciation And Amortization DepreciationAndAmortization	41237000	USD
CY2020	amn	Depreciation Included In Revenue DepreciationIncludedInRevenue	1421000	USD
CY2019	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2020	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	92766000	USD
CY2019	us-gaap	Depreciation And Amortization DepreciationAndAmortization	58520000	USD
CY2019	amn	Depreciation Included In Revenue DepreciationIncludedInRevenue	0	USD
CY2018	amn	Depreciation Included In Revenue DepreciationIncludedInRevenue	0	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	20465000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	16241000	USD
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	10815000	USD
CY2020	us-gaap	Interest Expense InterestExpense	57742000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2222107000	USD
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2136074000	USD
CY2019Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	114807000	USD
CY2018	us-gaap	Interest Expense InterestExpense	16143000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	91523000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	148488000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	186685000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2393714000	USD
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	99525000	USD
CY2019Q1	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	15302000	USD
	us-gaap	Number Of Businesses Acquired NumberOfBusinessesAcquired	6	acquisition
CY2018	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2019	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	690745000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	215234000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	475511000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	460491000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	151417000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	309074000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	564911000	USD
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	398474000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	63817000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	36493000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	61234000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	60351000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	58694000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	52161000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	39199000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	203872000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	475511000	USD
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2018Q4	us-gaap	Goodwill Goodwill	438506000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	595551000	USD
CY2020	amn	Goodwill Change In Goodwill Allocation GoodwillChangeInGoodwillAllocation	0	USD
CY2020Q4	us-gaap	Goodwill Goodwill	864485000	USD
CY2019Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	214939000	USD
CY2020Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	214939000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P10Y
CY2020	amn	Lessee Operating Lease Termination Period LesseeOperatingLeaseTerminationPeriod	P3Y
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	18733000	USD
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	20176000	USD
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	18725000	USD
CY2020	us-gaap	Short Term Lease Cost ShortTermLeaseCost	8702000	USD
CY2019	us-gaap	Short Term Lease Cost ShortTermLeaseCost	20112000	USD
CY2020	us-gaap	Variable Lease Cost VariableLeaseCost	2526000	USD
CY2019	us-gaap	Variable Lease Cost VariableLeaseCost	2880000	USD
CY2020	us-gaap	Lease Cost LeaseCost	31404000	USD
CY2019	us-gaap	Lease Cost LeaseCost	41717000	USD
CY2018	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	21402000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	19108000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	18552000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	18207000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	17030000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	15160000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	106790000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	13958000	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	92832000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	20052000	USD
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	17817000	USD
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y
CY2019Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y
CY2020Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.048
CY2019Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.048
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	18626000	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	18393000	USD
CY2020Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	6591000	USD
CY2019Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	37315000	USD
CY2020Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	220971000	USD
CY2019Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	5984000	USD
CY2020Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	15592000	USD
CY2019Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	16069000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	40809000	USD
CY2019Q4	us-gaap	Other Assets Current OtherAssetsCurrent	40446000	USD
CY2020Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	47355000	USD
CY2019Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	191050000	USD
CY2020Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	9600000	USD
CY2019Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	9367000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	277926000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	237732000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	161752000	USD
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	132900000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	116174000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	104832000	USD
CY2020Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	28089000	USD
CY2019Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	26985000	USD
CY2020Q4	amn	Accounts Payable To Subcontractor AccountsPayableToSubcontractor	79364000	USD
CY2019Q4	amn	Accounts Payable To Subcontractor AccountsPayableToSubcontractor	75562000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	37849000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	36344000	USD
CY2020Q4	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	7613000	USD
CY2019Q4	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	6146000	USD
CY2020Q4	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	8897000	USD
CY2019Q4	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	7925000	USD
CY2020Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	6069000	USD
CY2019Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	3178000	USD
CY2020Q4	amn	Accounts Payable And Accrued Expenses Excluding Accrued Compensation And Benefits Current AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent	167881000	USD
CY2019Q4	amn	Accounts Payable And Accrued Expenses Excluding Accrued Compensation And Benefits Current AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent	156140000	USD
CY2020Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	59721000	USD
CY2020Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	5590000	USD
CY2019Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	4019000	USD
CY2020Q4	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	10244000	USD
CY2019Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	20000000	USD
CY2019Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	47381000	USD
CY2020Q4	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	34514000	USD
CY2019Q4	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	22613000	USD
CY2020Q4	amn	Accrued Travel Expense AccruedTravelExpense	1998000	USD
CY2019Q4	amn	Accrued Travel Expense AccruedTravelExpense	2459000	USD
CY2019Q4	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	8782000	USD
CY2020Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	97184000	USD
CY2019Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	81064000	USD
CY2020Q4	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	4163000	USD
CY2019Q4	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	4614000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	213414000	USD
CY2019Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	170932000	USD
CY2020Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	8000000	USD
CY2019Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	5431000	USD
CY2020Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	2938000	USD
CY2019Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	5302000	USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	10938000	USD
CY2019Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	25302000	USD
CY2020Q4	us-gaap	Workers Compensation Liability Noncurrent WorkersCompensationLiabilityNoncurrent	20930000	USD
CY2019Q4	us-gaap	Workers Compensation Liability Noncurrent WorkersCompensationLiabilityNoncurrent	18291000	USD
CY2020Q4	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	31997000	USD
CY2019Q4	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	34606000	USD
CY2020Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	5447000	USD
CY2020Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	49533000	USD
CY2019Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	3485000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	107907000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	61813000	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	32673000	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	25255000	USD
CY2018	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	33564000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	9813000	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	8332000	USD
CY2018	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	12047000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	42486000	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	33587000	USD
CY2018	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	45611000	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-15092000	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	625000	USD
CY2018	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1372000	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-6536000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	913000	USD
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-667000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	20858000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	34500000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	44944000	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	288000	USD
CY2018	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	705000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-21628000	USD
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	19220000	USD
CY2019	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	31253000	USD
CY2018	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	39272000	USD
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	4161000	USD
CY2019	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	6810000	USD
CY2018	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	9902000	USD
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Meals And Entertainment IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment	3621000	USD
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense Meals And Entertainment IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment	3840000	USD
CY2018	us-gaap	Income Tax Reconciliation Nondeductible Expense Meals And Entertainment IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment	2956000	USD
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-2311000	USD
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-4770000	USD
CY2018	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-4343000	USD
CY2020	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	-78000	USD
CY2019	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	-207000	USD
CY2018	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	413000	USD
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-3755000	USD
CY2019	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-2426000	USD
CY2018	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-3256000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	20858000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	34500000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	44944000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	989000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	6198000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	5848000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	24604000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	20564000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Bonuses DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses	7607000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Bonuses DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses	4294000	USD
CY2020Q4	amn	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Payroll Taxes DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPayrollTaxes	12445000	USD
CY2019Q4	amn	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Payroll Taxes DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPayrollTaxes	60000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	18185000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	14218000	USD
CY2020Q4	amn	Deferred Tax Assets Operating Lease Liabilities DeferredTaxAssetsOperatingLeaseLiabilities	23826000	USD
CY2019Q4	amn	Deferred Tax Assets Operating Lease Liabilities DeferredTaxAssetsOperatingLeaseLiabilities	27206000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	9557000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3448000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Loss Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves	6459000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Loss Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves	0	USD
CY2020Q4	amn	Deferred Tax Liabilities Operating Lease Right Of Use Assets DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets	19933000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	570000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	109870000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	76208000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	126833000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	71646000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	25252000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	22896000	USD
CY2019Q4	amn	Deferred Tax Liabilities Operating Lease Right Of Use Assets DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets	23234000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	5057000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	5050000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	177075000	USD
CY2019Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	122826000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	67205000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	46618000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	0	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4937000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4393000	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4663000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	667000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	588000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	475000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	255000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	990000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	753000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	943000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	1034000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	547000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	0	USD
CY2018	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	951000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4916000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4937000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4393000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	4616000	USD
CY2020Q4	amn	Unrecognized Tax Benefits That Would Impact Effective Tax Rate Temporary Differences UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRateTemporaryDifferences	831000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	530000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	493000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	467000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	37000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	26000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	-139000	USD
CY2020Q4	amn	Deferred Payroll Taxes Cares Act DeferredPayrollTaxesCARESAct	48249000	USD
CY2020Q4	amn	Employee Retention Employment Tax Credit Cares Act EmployeeRetentionEmploymentTaxCreditCARESAct	1183000	USD
CY2020Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	871875000	USD
CY2019Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	625000000	USD
CY2020Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	9226000	USD
CY2019Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	7841000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	4688000	USD
CY2019Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	857961000	USD
CY2019Q4	us-gaap	Long Term Debt LongTermDebt	617159000	USD
CY2020	amn	Defined Contribution Plan Employer Discretionary Contribution Amount Net Of Forfeitures DefinedContributionPlanEmployerDiscretionaryContributionAmountNetOfForfeitures	4256000	USD
CY2019	amn	Defined Contribution Plan Employer Discretionary Contribution Amount Net Of Forfeitures DefinedContributionPlanEmployerDiscretionaryContributionAmountNetOfForfeitures	5516000	USD
CY2018	amn	Defined Contribution Plan Employer Discretionary Contribution Amount Net Of Forfeitures DefinedContributionPlanEmployerDiscretionaryContributionAmountNetOfForfeitures	5250000	USD
CY2020Q4	us-gaap	Cash Surrender Value Of Life Insurance CashSurrenderValueOfLifeInsurance	98161000	USD
CY2019Q4	us-gaap	Cash Surrender Value Of Life Insurance CashSurrenderValueOfLifeInsurance	79515000	USD
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	150000000	USD
CY2020	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0	shares
CY2019	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	395000	shares
CY2019	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	47.30
CY2019	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	18705000	USD
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	855000	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	30.98
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	499000	shares
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	23.04
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	83000	shares
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	42.32
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	818000	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	43.84
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	400000	shares
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	35.46
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	52000	shares
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	41.09
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	758000	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	52.45
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	283000	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	49.18
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	184000	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	53.84
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	717000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	58.88
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	20465000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	16241000	USD
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10815000	USD
CY2020	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	5321000	USD
CY2019	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	4223000	USD
CY2018	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	2812000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	15144000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	12018000	USD
CY2018	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	8003000	USD
CY2020Q2	us-gaap	Gross Profit GrossProfit	197540000	USD
CY2020Q3	us-gaap	Gross Profit GrossProfit	184633000	USD
CY2020Q4	us-gaap	Gross Profit GrossProfit	207539000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	602461000	USD
CY2020Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	608351000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	551631000	USD
CY2020Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	631271000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2393714000	USD
CY2020Q1	us-gaap	Gross Profit GrossProfit	202066000	USD
CY2020	us-gaap	Gross Profit GrossProfit	791778000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	12965000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	22325000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	26067000	USD
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	9308000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	70665000	USD
CY2019Q2	us-gaap	Gross Profit GrossProfit	179542000	USD
CY2019Q3	us-gaap	Gross Profit GrossProfit	190031000	USD
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.27
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.47
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.55
CY2020Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.20
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.49
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.27
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.47
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.55
CY2020Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.19
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.48
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	532441000	USD
CY2019Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	535177000	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	567597000	USD
CY2019Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	586892000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2222107000	USD
CY2019Q1	us-gaap	Gross Profit GrossProfit	176759000	USD
CY2019Q4	us-gaap	Gross Profit GrossProfit	197133000	USD
CY2019	us-gaap	Gross Profit GrossProfit	743465000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	34122000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	28869000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	23515000	USD
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	27482000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	113988000	USD
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.73
CY2019Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.62
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.50
CY2019Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.59
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.44
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.71
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.61
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.49
CY2019Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.58
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.40

Files In Submission

Name	View Source	Status
0001142750-21-000012-index-headers.html	Edgar Link	pending
0001142750-21-000012-index.html	Edgar Link	pending
0001142750-21-000012.txt	Edgar Link	pending
0001142750-21-000012-xbrl.zip	Edgar Link	pending
amn-20201231.htm	Edgar Link	pending
amn-20201231.xsd	Edgar Link	pending
amn-20201231_cal.xml	Edgar Link	unprocessable
amn-20201231_def.xml	Edgar Link	unprocessable
amn-20201231_g1.jpg	Edgar Link	pending
amn-20201231_g2.jpg	Edgar Link	pending
amn-20201231_htm.xml	Edgar Link	completed
amn-20201231_lab.xml	Edgar Link	unprocessable
amn-20201231_pre.xml	Edgar Link	unprocessable
amn-ex211x20201231x10k.htm	Edgar Link	pending
amn-ex231x20201231x10k.htm	Edgar Link	pending
amn-ex311x20201231x10k.htm	Edgar Link	pending
amn-ex312x20201231x10k.htm	Edgar Link	pending
amn-ex321x20201231x10k.htm	Edgar Link	pending
amn-ex322x20201231x10k.htm	Edgar Link	pending
amn-ex45x20201231x10k.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AMN
AMN HEALTHCARE SERVICES INC Stock $amn

2020 Q4 Form 10-K Financial Statement

#000114275021000012 Filed on February 26, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMN AMN HEALTHCARE SERVICES INC Stock $amn

2020 Q4 Form 10-K Financial Statement

#000114275021000012 Filed on February 26, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMN
AMN HEALTHCARE SERVICES INC Stock $amn